Category: Clinical Trial
Clinical Trial market research reports by Nova One Advisor
-
In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type (Rodent Based, Non-rodent Based), By Modality (Small Molecule, Large Molecule), By Indication, By GLP Type (Non GLP, GLP Toxicology), By Region, )- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
In Vivo CRO Market Size and Growth The global in Vivo CRO market size was valued at USD 6.19 billion in 2023 and is anticipated to reach around USD 13.74 billion by 2033, growing at a CAGR of 8.34% from 2024 to 2033. In Vivo CRO Market Key Takeaways In 2023, the rodent based segment dominated the ma ... Read More
-
Cell And Gene Therapy CDMO Market Size, Share & Trends Analysis Report By Phase (Pre-clinical, Clinical), By Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Indication (Oncology, Infectious Diseases), By Region, And Segment- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global Cell And Gene Therapy CDMO market size was estimated at USD 5.90 billion in 2023 and is projected to hit around USD 69.11 billion by 2033, growing at a CAGR of 27.9% during the forecast period from 2024 to 2033. Key Takeaways: North America accounts for the largest share of 40.18% in 2023 ... Read More
-
U.S. Pharmaceutical CDMO Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2034
U.S. Pharmaceutical CDMO Market Size and Growth The U.S. pharmaceutical CDMO market size was exhibited at USD 40.65 billion in 2024 and is projected to hit around USD 83.86 billion by 2034, growing at a CAGR of 7.51% during the forecast period 2024 to 2034. The U.S. pharmaceutical CDMO market growth ... Read More
-
U.S. Cell And Gene Therapy Clinical Trial Services Market Size, Share & Trends Analysis Report By Service (Site Identification, Patient Recruitment), By Phase (Phase I, Phase II), By Therapeutic Areas, By Therapy Type, And Segment) - Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033
The U.S. cell and gene therapy clinical trial services market size was valued at USD 7.19 billion in 2023 and is projected to surpass around USD 56.53 billion by 2033, registering a CAGR of 22.9% over the forecast period of 2024 to 2033. Key Takeaways: The regulatory services segment held the larges ... Read More